Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

dihydrosomatostatin

Known as: somatostatin (15-28) 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1985
1985
High plasma concentrations of C-terminal immunoreactive glucagon (IRG) have been found during early life in several mammalian… Expand
Highly Cited
1981
Highly Cited
1981
Comparative studies of the activity of somatostatin and of several of its analogues in releasing histamine from rat mast cells… Expand
1981
1981
To exemplify the usefulness of the S‐tert‐butylthio group for a reversible blocking of the cysteine thiol function in peptide… Expand
Highly Cited
1980
Highly Cited
1980
Experimental details for the "Fmoc solid phase peptide synthesis" of somatostatin are described. The 9-fluorenylmethyloxycarbonyl… Expand
1980
1980
Experimental details for practical syntheses of somatostatin and D-Trp8-somatostatin are described. The peptides were assembled… Expand
Highly Cited
1978
Highly Cited
1978
N alpha-9-Fluorenylmethyloxycarbonyl (Fmoc) amino acids will be of advantage in solid phase peptide synthesis. The Fmoc-group is… Expand
Highly Cited
1976
Highly Cited
1976
Somatostatin and dihydrosomatostatin (H2somatostatin) are equipotent in inhibiting insulin and glucagon release induced by… Expand
Highly Cited
1975
Highly Cited
1975
An in vitro system which uses perifused pieces from the antrum of rat stomach has been used to study the effect of… Expand
Highly Cited
1974
Highly Cited
1974
Abstract Dihydrosomatostatin (0.001–1.0 ug/ml) inhibited both insulin and glucagon secretion by monolayer cell cultures of… Expand